Flexible Sigmoidoscopy vs. Colonoscopy: The Differences

Flexible sigmoidoscopy and colonoscopy use similar technology but examine different lengths of the large intestine, and that single distinction drives almost every other difference between them: what they can find, how much preparation they require, how safe they are, and how effectively they prevent cancer deaths. A colonoscopy inspects the entire colon and rectum, while a flexible sigmoidoscopy covers roughly the lower third. The procedures share a basic tool, a long flexible tube with a camera and light, but the trade-offs in reach, risk, preparation burden, and protective benefit are substantial enough that guidelines treat them as genuinely different screening options.

How Far Each Procedure Reaches

Your colon is roughly 150 to 170 centimeters long. A colonoscopy aims to traverse all of it, from the rectum up through the sigmoid, descending, transverse, and ascending colon to the cecum, which sits near the appendix. A flexible sigmoidoscopy, by contrast, is designed to examine just the rectum and sigmoid colon, sometimes reaching into the lower descending colon. In practice, a study measuring actual insertion depth found a median reach of 52 centimeters, and in most patients the scope never made it past the junction between the sigmoid and descending colon.

This matters because colorectal cancer and precancerous polyps can develop anywhere along the colon. Roughly a quarter to a third of people with polyps in the rectosigmoid region also have polyps farther upstream, in the so-called proximal colon.

² And a meta-analysis found that among people with no polyps visible in the distal colon at all, roughly 2 to 3 percent still harbored advanced adenomas higher up, completely beyond the reach of a sigmoidoscope.³ That small but real percentage is the core limitation of sigmoidoscopy as a screening tool: it cannot see what it cannot reach.

How Much Each Procedure Reduces Cancer Deaths

Both procedures lower the risk of dying from colorectal cancer, but colonoscopy does so more comprehensively. A large case-control analysis found that flexible sigmoidoscopy was associated with about a 35 percent reduction in overall colorectal cancer mortality, while colonoscopy was associated with roughly a 74 percent reduction.⁴ The gap is mostly explained by anatomy. Sigmoidoscopy cut distal colorectal cancer deaths by about 55 percent but had no measurable effect on cancers in the proximal colon. Colonoscopy reduced distal cancer deaths even more and also significantly reduced proximal cancer deaths.

A 2024 meta-analysis pooling seven randomized controlled trials with over 660,000 participants found that endoscopic screening overall (combining colonoscopy and sigmoidoscopy data) reduced colorectal cancer incidence by about 20 percent and colorectal cancer mortality by about 26 percent compared with usual care.⁵ The NordICC trial, one of the largest colonoscopy-specific randomized trials, reported an 18 percent reduction in colorectal cancer risk at ten years among people invited to screening, though the mortality reduction did not reach statistical significance by that follow-up point.⁶ That trial measured the effect of the invitation rather than the procedure itself, and only about 42 percent of those invited actually underwent colonoscopy, which diluted the apparent benefit. Researchers expect the per-protocol effect to be considerably larger as longer follow-up data accumulate.

For sigmoidoscopy specifically, a modeling study found that without any follow-up colonoscopy referral, sigmoidoscopy’s sensitivity for detecting any colorectal cancer was about 79 percent. When the screening program included referral for colonoscopy in people whose sigmoidoscopy found worrisome polyps, sensitivity climbed to about 86 percent.⁷ In other words, sigmoidoscopy works best as a first step that triggers a colonoscopy when something suspicious turns up.

Safety and Complication Rates

Both procedures are safe in absolute terms, but sigmoidoscopy carries a lower risk of the two most serious complications: bleeding and perforation. A systematic review of screening-related complications estimated bleeding at about 8 per 100,000 people screened for sigmoidoscopy, compared with about 68 per 100,000 for once-only colonoscopy.⁸ When colonoscopy followed a positive stool test, the bleeding rate was higher still, roughly 229 per 100,000, reflecting the fact that those patients are more likely to have polyps that get removed during the procedure.

An analysis cited in a separate large review estimated bleeding at about 5 per 1,000 colonoscopies and perforation at about 0.5 per 1,000, versus about 0.3 per 1,000 for both complications during sigmoidoscopy.⁹ A population-based study found perforation rates of roughly 2 per 1,000 colonoscopies versus about 0.9 per 1,000 sigmoidoscopies, with an adjusted odds of perforation about 1.8 times higher for colonoscopy.¹⁰

Several factors explain the difference. Colonoscopy involves navigating a longer, more tortuous path, which puts more mechanical stress on the colon wall. The procedure also more frequently involves polypectomy, the act of snipping out polyps, which itself carries a small risk of bleeding. Sigmoidoscopy, being shorter and often not involving sedation, is inherently gentler on the tissue.

Preparation and What to Expect

If you have ever heard someone complain about colonoscopy prep, they are talking about the full bowel cleanout: drinking large volumes of a laxative solution the evening before (and sometimes again the morning of) to empty the entire colon. The process takes hours, causes frequent trips to the bathroom, and is consistently rated by patients as the worst part of the experience.¹¹ The rationale is that the endoscopist needs a clear view of all 150-plus centimeters of colon.

Sigmoidoscopy prep is lighter. Because only the lower colon needs to be clean, an enema shortly before the procedure is often sufficient. Some practices use a small-volume oral prep instead. A randomized trial comparing the two approaches for sigmoidoscopy found that patients given an oral prep rated it as easy or tolerable 97 percent of the time, compared with about 56 percent for enema prep, while endoscopists graded the view as good or excellent more often with the oral prep.¹² A systematic review of multiple trials, however, found no clear winner overall, concluding that enema and oral prep produced similar rates of incomplete procedures and similar complication rates.¹³ Either way, the preparation for sigmoidoscopy is substantially less burdensome than the full-day cleanout required for colonoscopy.

Colonoscopy also typically involves sedation, usually moderate (conscious) sedation or sometimes deeper sedation with propofol, which means you need someone to drive you home and you may lose the rest of your day. Sigmoidoscopy is usually performed without sedation or with only light sedation. That makes the overall time commitment shorter: walk in, get the scope, walk out. The trade-off is that without sedation, you feel more during the procedure itself.

Comfort During the Procedure

You might assume the shorter procedure would be the more comfortable one, but it is not quite that simple. In a study directly comparing patient experiences, 75 percent of people who had a sedated colonoscopy described the experience as comfortable, compared with just 18 percent of those who had an unsedated flexible sigmoidoscopy.¹¹ Most sigmoidoscopy patients reported mild pain (scoring below 3 on an 11-point scale), with women reporting somewhat more discomfort than men. Embarrassment was low and similar for both procedures, around 8 percent.

The interesting flip was what patients said about the worst part. For colonoscopy patients, 78 percent named the preparation as the worst part, not the procedure itself. For sigmoidoscopy patients, the preparation and the procedure ranked equally as the worst component. This tracks with the lighter prep burden: when the preparation is not that bad, the procedure itself has a chance to be the most unpleasant part. When the preparation is grueling, the actual scope barely registers in comparison because you are sedated through it.

Research on overall screening acceptability suggests that stool-based tests like fecal immunochemical tests (FIT) are generally seen as more acceptable than either endoscopic option.¹⁴ That makes sense: mailing in a stool sample from home requires no bowel prep, no time off work, no sedation, and no endoscope. But stool tests need to be repeated frequently and have a higher false-positive rate, meaning some people end up getting a colonoscopy anyway to follow up on an abnormal result.

Screening Intervals and Current Guidelines

The US Preventive Services Task Force recommends starting colorectal cancer screening at age 45, continuing through age 75, with selective screening for adults 76 to 85 based on individual health and screening history.¹⁵ Several modalities are endorsed, and the recommended intervals differ substantially:

Colonoscopy: every 10 years
Sigmoidoscopy alone: every 5 years
Sigmoidoscopy plus annual FIT: sigmoidoscopy every 10 years with an annual stool test between scopes
Stool tests alone: FIT every year, or stool DNA-FIT every 1 to 3 years

The guidelines are agnostic about which option is “best.” The consistent message from major organizations is that the best screening test is the one you will actually complete.¹⁶ A perfect colonoscopy every 10 years means nothing if someone keeps canceling the appointment because they dread the prep. A sigmoidoscopy every 5 years, or even an annual stool test, is far better than no screening at all.

Cost and Cost-Effectiveness

Colonoscopy is the more expensive procedure. It requires more physician time, an anesthesia or sedation team, a longer recovery period, and a more fully equipped facility. The full bowel prep also generates more patient cost in terms of time away from work. Sigmoidoscopy can often be performed in an office setting without sedation staff.

Cost-effectiveness modeling, though, shows both procedures deliver good value compared with no screening. A modeling study found that strategies combining sigmoidoscopy with an annual stool test fell on the “efficient frontier,” meaning they produced near-maximal life-years saved for their cost.¹⁷ A separate analysis estimated that colonoscopy cost about $56,800 per quality-adjusted life-year gained compared with sigmoidoscopy, which is well within what is conventionally considered good value in healthcare economics. When stool-test adherence was poor, both endoscopic options became even more cost-effective relative to stool-based strategies.¹⁸

Interval Cancers and Missed Lesions

An interval cancer is one diagnosed between scheduled screening exams, meaning the previous screening either missed it or it grew quickly after a clean result. Both procedures have some miss rate, but sigmoidoscopy’s is higher, especially for left-sided cancers in the descending colon. Among older patients with left-sided colorectal cancer, about 8.8 percent were interval cancers after a prior sigmoidoscopy, compared with 2.5 percent after a prior colonoscopy. The odds of interval cancer after sigmoidoscopy were roughly three times as high.¹⁹

Examiner skill matters for both procedures. In the large PLCO cancer screening trial, patients whose sigmoidoscopy was performed by an endoscopist in the lowest quartile of adenoma detection had interval distal cancer rates about twice as high as those screened by higher-detecting examiners.²⁰ This mirrors a well-known finding in the colonoscopy world: the adenoma detection rate of the individual endoscopist is one of the strongest predictors of how well the procedure protects you. A careful, thorough examiner makes a bigger difference than which procedure you choose.

When Colonoscopy Cannot Be Completed

Colonoscopy aims for the cecum, but it does not always get there. A study of patients referred for CT colonography after an incomplete optical colonoscopy found that the most common reasons for failure were diverticular disease, a redundant (extra-long or extra-loopy) colon, and prior abdominal adhesions from surgery.²¹ Women, older adults, and people with prior abdominal surgery are more likely to have incomplete colonoscopies.²² Longer total colorectal length, a longer sigmoid colon, more flexures, and advanced diverticular disease were all independent predictors of failure.

When a colonoscopy cannot be completed, the portion that was examined is essentially a long sigmoidoscopy. The patient still needs the unseen proximal segments evaluated, typically through CT colonography (a specialized CT scan of the colon) or a repeat attempt under different conditions. For some patients with very tortuous anatomy, sigmoidoscopy combined with periodic stool testing may end up being the practical long-term screening plan, not because it is preferred, but because full colonoscopy is not anatomically achievable.

Beyond Screening: Sigmoidoscopy for Ulcerative Colitis

Flexible sigmoidoscopy has a significant role outside cancer screening, particularly in managing ulcerative colitis. Because UC almost always involves the rectum and extends proximally in a continuous pattern, the rectosigmoid region captured by sigmoidoscopy reliably reflects overall disease severity. A study directly comparing endoscopic scores from sigmoidoscopy and full colonoscopy in UC patients found a high correlation for both initial diagnosis and treatment follow-up, concluding that sigmoidoscopy was as effective as colonoscopy for monitoring disease activity and therapeutic response.²³

In acute severe UC flares requiring hospitalization, early sigmoidoscopy appears to improve outcomes. One study found that patients who received sigmoidoscopy early in their hospital stay had shorter courses of intravenous steroids (about 4.5 versus 9 days), much shorter hospital stays (about 6 versus 19 days), and faster time to rescue therapy when steroids failed.²⁴ A larger analysis of UC-related hospitalizations found that delayed endoscopy was associated with higher in-hospital mortality, longer stays, and increased costs, with the association strongest in patients with intermediate disease severity.²⁵ In this setting, sigmoidoscopy is not just an alternative to colonoscopy but is often the preferred tool: it is faster, does not require full bowel prep in an acutely ill patient, and gives the gastroenterologist enough information to make treatment decisions without the added risk of navigating an inflamed and fragile colon from end to end.

AI-Assisted Colonoscopy and the Evolving Technology Gap

One area where the two procedures may diverge further in coming years is artificial intelligence. AI systems that highlight suspicious areas in real time during endoscopy have been integrated into colonoscopy practice at a growing number of centers. A retrospective study comparing AI-assisted colonoscopy to standard colonoscopy found that the AI group had an adenoma detection rate of about 36 percent versus 26 percent without AI, a clinically meaningful improvement.²⁶ Most of this AI development has focused on colonoscopy rather than sigmoidoscopy, partly because colonoscopy is where the detection challenge is greatest (more surface area, more opportunities to miss flat or subtle lesions) and partly because colonoscopy dominates screening programs in countries investing heavily in endoscopy technology.

If AI meaningfully narrows the gap between average and expert endoscopists during colonoscopy, the quality-dependent advantages of colonoscopy over sigmoidoscopy could widen. Right now, a skilled sigmoidoscopist doing a thorough exam of the distal colon still provides real protection. But if AI-assisted colonoscopy consistently catches more polyps that humans miss, the relative appeal of the shorter procedure may diminish for patients who can tolerate the full exam. That said, AI-assisted sigmoidoscopy is also plausible and could improve detection within its more limited field of view, though published data on that application remain thin.